Device Firms Criticize FDA Proposals To Share More Pre-Market Intel
This article was originally published in The Gray Sheet
Executive Summary
Device and drug makers say FDA's draft proposals for publicly releasing more information on product applications would cripple the industry without providing much benefit to patients